Observational study on the effects of immunosuppressive therapy in uveitis associated with rheumatic diseases
의약학 > 내과학
( Lee Sang Yeob ) , ( Kim Yong Jun ) , ( Kang San Hyeon ) , ( Lee Dong Yeol ) , ( Cho Duk Song ) , ( Kim Kyong Han ) , ( Lee Sung Won ) , ( Chung Won Tae )
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 324(총1페이지)
42846798.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    The purpose of this study was to compare with uveitis accompanied rheumatic disease and uveitis unaccompanied rheumatic disease in immunosuppressive therapy response. An observational study was conducted of 432 patients diagnosed with uveitis who visited the rheumatologic department to evaluate with rheumatic disease between 2000 and 2009. We divided patients into two groups: uveitis related to rheumatic disease and unrelated to rheumatic disease. All patients were treated and a response to treatment was measured at the end of the observation period. The 432 patients were diagnosed to uveitis, 33 (7.6%) patients had rheumatic diseases related uveitis and 399 (92.4%) patients had uveitis unrelated rheumatic disease. the each group were similar to gender and body mass index. but the mean age at onset of uveitis was younger uveitis with rheumatic disease than uveitis without rheumatic disease(44.06 vs 48.23 years). The rheumatic disease accompanied uveitis was consisted of spondyloarhtropathy (31%), bechet`s disease (27%), rheumatoid arthritis (18%), systemic lupus erythematosus (15%), sjogren`s syndrome (6%) and mixed connective tissue disease (3%). The state of inflammation, ESR and CRP levels in patients with uveitis associated with rheumatic diseases were increased but the ocular complications did not increase in uveitis associated with rheumatic disease. The response of immunosuppressive therapy in patients with uveitis associated with rheumatic diseases was good and was statistically significant (p<0.05). The uveitis accompanied rheumatic disease was better response to immunosuppressive therapy and less frequent complications than uveitisu naccompanied rheumatic disease in early treatment.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.